(Q34439240)

2 August 2017

title

Potential markers that complement expression of CA125 in epithelial ovarian cancer (English)

1 reference

2 August 2017

1 reference

Eleftherios P. Diamandis

6

object named as

Eleftherios P Diamandis

1 reference

2 August 2017

Robert C Bast

10

0 references

Karen H. Lu

5

object named as

Karen H Lu

1 reference

2 August 2017

Daniel G Rosen

1

1 reference

2 August 2017

Lin Wang

2

1 reference

2 August 2017

J Neeley Atkinson

3

1 reference

2 August 2017

Yinhua Yu

4

1 reference

2 August 2017

Ingegerd Hellstrom

7

1 reference

2 August 2017

Samuel C Mok

8

1 reference

2 August 2017

Jinsong Liu

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

2 August 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

99

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

267-277

1 reference

2 August 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Osteopontin as a potential diagnostic biomarker for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Validation of tissue microarray technology in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The CA 125 tumour-associated antigen: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The emerging roles of human tissue kallikreins in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Predicting biomarkers for ovarian cancer using gene-expression microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Differential gene expression in ovarian carcinoma: identification of potential biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Osteopontin expression in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The role of osteopontin in breast cancer: clinical and experimental studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The functional and clinical roles of osteopontin in cancer and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Osteopontin: a versatile regulator of inflammation and biomineralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Osteopontin--a possible anchor of osteoclasts to bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Multifunctional strands in tight junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Tissue and Serum MUC1 Mucin Detection in Breast Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Vascular endothelial growth factor in adnexal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Vascular endothelial growth factor serum concentrations in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Angiogenesis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

Prospective on ovarian cancer: why prevent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2005.06.040

1 reference

2 August 2017

1 reference